ANTX: AN2 Therapeutics, Inc. Stock

SIC 6324 – Hospital and Medical Service Plans

Valuation
Market Cap ($M) 33.76
Enterprise Value ($M) 0.26
Book Value ($M) 87.67
Book Value / Share 2.93
Price / Book 0.39
NCAV ($M) 87.67
NCAV / Share 2.93
Price / NCAV 0.39

Profitability (mra)
Return on Invested Capital (ROIC) -0.69
Return on Assets (ROA) -0.44
Return on Equity (ROE) -0.49

Liquidity (mrq)
Quick Ratio 9.75
Current Ratio 9.75

Balance Sheet (mrq) ($M)
Current Assets 97.69
Assets 97.69
Liabilities 10.02
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
9 days ago 13G/A Frazier Life Sciences Public Fund, L.P.
9 days ago 13G/A Ra Capital Management, L.p.
9 days ago 13G/A TCG Crossover GP I, LLC
9 days ago 13G/A Brii Biosciences Ltd
02-13 13G/A Easom Eric
02-13 13G/A BML Investment Partners, L.P.
11-14 13G/A Citadel Advisors Llc 0.00
11-14 13G/A Biotechnology Value Fund L P 0.00 -100.00
08-28 13G/A Octagon Capital Advisors LP 0.00 -100.00
2024-02-12 13G/A Janus Henderson Group Plc 4.30 27.99
2024-02-09 13G/A Adjuvant Global Health Technology Fund, L.P. 8.30 -4.77

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-17 10-Q FINANCIAL STATEMENTS
2024-07-17 10-Q FINANCIAL STATEMENTS
2024-04-18 10-Q FINANCIAL STATEMENTS

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 94,958 324,668 29.25
2025-02-20 44,932 106,979 42.00
2025-02-19 58,048 113,133 51.31
2025-02-18 62,867 218,128 28.82

(click for more detail)

Similar Companies
ALHC – Alignment Healthcare, Inc. CLOV – Clover Health Investments, Corp.
PFG – Principal Financial Group, Inc.


Financial data and stock pages provided by
Fintel.io